BCRX CIK: 882796

BioCryst Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.57
FY22:
0.52
FY23:
0.50
FY24:
0.42
FY25:
0.40
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.03
FY23:
0.02
FY24:
0.07
FY25:
0.11
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.59
FY22:
0.55
FY23:
0.52
FY24:
0.49
FY25:
0.51

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.11
FY23:
0.15
FY24:
0.16
FY25:
0.20
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.59
FY22:
0.74
FY23:
0.82
FY24:
0.81
FY25:
0.44
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.11
FY22:
−0.29
FY23:
−0.46
FY24:
−0.48
FY25:
−0.12
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.59
FY22:
0.55
FY23:
0.52
FY24:
0.49
FY25:
0.51

All amounts in billions USD Data sources:SEC EDGARTwelve Data